Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play

Our understanding of neuroendocrine prostate cancer (NEPC) has assumed a new perspective in light of the recent advances in research. Although classical NEPC is rarely seen in the clinic, focal neuroendocrine trans-differentiation of prostate adenocarcinoma occurs in about 30% of advanced prostate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Girijesh Kumar, Chugh, Natasha, Tripathi, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826557/
https://www.ncbi.nlm.nih.gov/pubmed/31547070
http://dx.doi.org/10.3390/cancers11101405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826557/
https://www.ncbi.nlm.nih.gov/pubmed/31547070
http://dx.doi.org/10.3390/cancers11101405

Ejemplares similares